Lucas from Germany

Registered at the short selling broker Skilling, 3 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Novartis AG (NVS) shares information

Novartis AG – ADR


24h Change

0.74 %

NVS

Live rate: Market closed

Stock data per Tuesday 28 Mar, 2023

NVS
NEW YORK STOCK EXCHANGE INC.
90.28
89.96
90.95
0.67 (+ 0.74%)
US Market is closed

Live Stock price in graph for Novartis AG – ADR (NVS)

  • Latest Volume

    3,460,523 (-45.63 %)

  • Volume prev. day

    6,364,492

  • Avg. daily volume

    2,410,775

  • Market cap

    218,618,447,869

  • P/E ratio

    28.69

  • Today high

    91.065 USD

  • Today low

    89.76 USD

  • 52 week high

    91.065 USD

  • 52 week low

    71 USD

  • YTD Change

    + 4.58 %

Quick links

 

Latest news about Novartis AG – ADR

Below you can find the most recent news posts about Novartis AG – ADR, primarily from US and UK based news sources.

BofA Securities maintains Novartis at Buy

Wednesday, 29 March 2023, 03:36:35
https://www.investing.com/news/pro/novartis-receives-investment-bank-analyst-rating-update-3043349
— Investing.com


Novartis Puts Up $50M to Steer Bicycle Therapeutics’ Tech Into New Cancer Meds – MedCity News

Wednesday, 29 March 2023, 01:26:35
Novartis is partnering with Bicycle Therapeutics to see if the biotech’s technology can be used to develop better, more targeted radiopharmaceuticals. The deal covers two targets that were not disclosed.
— MedCity News


Bicycle Therapeutics In Deal With Novartis To Develop Bicycle Radio-conjugates

Tuesday, 28 March 2023, 15:10:18
… into a partnership with Swiss Pharma major Novartis AG to develop, and … oncology targets. Bicycle Therapeutics develops drugs based on its proprietary bicyclic … Bicycle-based medicines commercialized by Novartis . “This collaboration builds on …
— EIN News Pharmaceuticals


Health Care Roundup: Market Talk

Tuesday, 28 March 2023, 14:17:00
Find insight on Evotec, Novartis and more in the latest Market Talks covering the Health Care sector.
— The Wall Street Journal


Bicycle stock pops on cancer drug discovery pact with Novartis, gets $50M upfront

Tuesday, 28 March 2023, 13:27:49
Bicycle Therapeutics (BCYC) signed an agreement with Novartis (NVS) to develop and sell radio-conjugates for oncology targets. Read more here
— Seeking Alpha


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have NVS available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.